ED
AZN icon

Exane Derivatives’s AstraZeneca AZN Stock Holding History

Exane Derivatives’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Hold
0
– – – 628
2017
Q4 		– Hold
0
– – – 610
2017
Q3 		– Sell
-11,577
Closed -$731K – 577
2017
Q2 		$789K Sell
11,577
-29,173
-72% -$1.91M 0.22% 100
2017
Q1 		$2.54M Sell
40,750
-36,823
-47% -$2.14M 0.65% 58
2016
Q4 		$4.24M Sell
77,573
-45,065
-37% -$2.56M 1% 21
2016
Q3 		$8.06M Buy
+122,638
New +$8.02M 1.51% 26
2016
Q2 		– Hold
0
– – – 557
2015
Q4 		– Hold
0
– – – 522
2015
Q3 		– Hold
0
– – – 539
2015
Q2 		– Hold
0
– – – 525
2015
Q1 		– Sell
-1,597
Closed -$111K – 519
2014
Q4 		$112K Buy
+1,597
New +$114K 0.02% 274

Other funds holding AZN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return